|
Allergan did not submit this mdr within 30 days of becoming aware.Recent stimulated reporting related to 2011068-7/2/19-001-r has increased complaint and mdr volume.Allergan is implementing a plan to address the increased volumes.A review of the device history record has been initiated.If any new, changed or corrected information is noted, a supplemental medwatch will be submitted.Device evaluation: visual analysis of the returned device identified deformation, crease fold, wear abrasion, black particles, and voids/bubbles in the gel were observed after autoclave disinfection cycle.Weight measurement of the device identified device was overweight, however a review of the weight reports generated during the manufacturing process was performed, and all units were within specification.Therefore, the overweight observed during the additional analysis was not considered workmanship.Based on the device analysis the final assessment was no issues found related with the manufacturing process.The event of "capsular contracture" is a physiological complication and analysis of the device generally does not assist allergan in determining a probable cause for this event.Further information from the reporter regarding event, product, or patient details has been requested.No additional information is available at this time.Reason for reoperation: capsular contracture, baker grade unknown.
|